Biofabri and TBVI sign a contract with the European Health and Digital Executive Agency to accelerate the final development of the new TB vaccine MTBVAC
Second call for applications to assess efficacy of Mycobacterium tuberculosis vaccine candidates in a mouse model
MTBVAC, the first vaccine against Tuberculosis derived from a human source, begins clinical trials in adults in India.
Bill & Melinda Gates Medical Research Institute Initiates Phase 3 Clinical Trial of Tuberculosis Vaccine Candidate
Call for applications to assess efficacy of Mycobacterium tuberculosis vaccine candidates in a mouse model
